Iradimed (IRMD) Receivables - Net (2013 - 2026)

Iradimed (IRMD) has 14 years of Receivables - Net data on file, last reported at $13.4 million in Q1 2026.

• Quarterly Receivables - Net rose 5.58% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.4 million (up 5.58% YoY) and the FY2025 annual result came in at $13.7 million, up 29.47% from the prior year.
• Receivables - Net retreated to $13.4 million in Q1 2026 per IRMD's latest filing, from $13.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $13.9 million in Q3 2025 and bottomed at $6.5 million in Q1 2022.
• The 5-year median for Receivables - Net is $12.0 million (2024), against an average of $11.6 million.
• The widest annual swing landed in 2022, when Receivables - Net jumped 158.43%; it then retreated 18.92% in 2024.
• Tracing IRMD's Receivables - Net over 5 years: stood at $13.3 million in 2022, then fell by 7.91% to $12.2 million in 2023, then slipped by 13.65% to $10.6 million in 2024, then rose by 29.47% to $13.7 million in 2025, then retreated by 1.84% to $13.4 million in 2026.
• Per Business Quant, the three latest IRMD Receivables - Net figures stand at $13.4 million (Q1 2026), $13.7 million (Q4 2025), and $13.9 million (Q3 2025).

Peer Comparison